Related Experiment Video
Updated: Oct 4, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Dysfunctional Network and Mutation Genes of Hypertrophic Cardiomyopathy
Yunwen Cui1, Cheng Liu1, Jian Luo1
1The First Affiliated Hospital of Xinjiang Medical University, No. 1 Liyushan Road, Xinshi, Urumqi 830054, China.
Insights
This study identifies key genes and pathways involved in hypertrophic cardiomyopathy (HCM). PRMT5 mutations are highlighted as potential diagnostic and therapeutic targets for this common familial heart disease.
Area of Science:
- Cardiovascular Genetics
- Molecular Biology
- Systems Biology
Background:
- Hypertrophic cardiomyopathy (HCM) is a complex, often familial myocardial disease with varied presentation.
- Identifying the underlying genetic and molecular mechanisms of HCM is crucial for diagnosis and treatment.
Purpose of the Study:
- To analyze the dysfunctional gene network in hypertrophic cardiomyopathy (HCM).
- To screen for key target genes with diagnostic and therapeutic significance in HCM.
Main Methods:
- Downloaded and analyzed gene expression profiles (GSE130036) to identify differentially expressed genes in HCM.
- Utilized enrichment analysis, protein-protein interaction (PPI) network construction, and single-nucleotide variant (SNV) screening (maftools).
- Verified gene expression trends using an independent dataset (GSE36961) and quantitative real-time polymerase chain reaction (qRT-PCR).
Main Results:
- Identified 920 differentially expressed genes, primarily linked to metabolism-related pathways.
- Discovered 187 interacting genes via PPI network analysis, with specific genes (C1QB, F13A1, CD163, FCN3, PLA2G2A, CHRDL2) showing diagnostic potential.
- Found PRMT5 mutations to be frequent in HCM samples, suggesting a role in pathogenesis.
Conclusions:
- The identified key genes and pathways offer insights into HCM's development mechanism.
- PRMT5 mutations represent a promising therapeutic and diagnostic target for hypertrophic cardiomyopathy.
- This research provides a quantitative assessment for functional limitations in HCM patients.
Background:
Hypertrophic cardiomyopathy (HCM) is a group of heterogeneous diseases that affects the myocardium. It is also a common familial disease. The symptoms are not common and easy to find.
Objective:
In this paper, we aim to explore and analyze the dysfunctional gene network related to hypertrophic cardiomyopathy, and the key target genes with diagnostic and therapeutic significance for HCM were screened.
Methods:
The gene expression profiles of 37 samples (GSE130036) were downloaded from the GEO database. Differential analysis was used to identify the related dysregulated genes in patients with HCM. Enrichment analysis identified the biological function and signaling pathway of these differentially expressed genes. Then, PPI network was built and verified in the GSE36961 dataset. Finally, the gene of single-nucleotide variants (SNVs) in HCM samples was screened by means of maftools.
Results:
In this study, 920 differentially expressed genes were obtained, and these genes were mainly related to metabolism-related signaling pathways. 187 interacting genes were identified by PPI network analysis, and the expression trends of C1QB, F13A1, CD163, FCN3, PLA2G2A, and CHRDL2 were verified by another dataset and quantitative real-time polymerase chain reaction. ROC curve analysis showed that they had certain clinical diagnostic ability, and they were the potential key dysfunctional genes of HCM. In addition, we found that PRMT5 mutation was the most frequent in HCM samples, which may affect the pathogenesis of HCM.
Conclusion:
Therefore, the key genes and enrichment results identified by our analysis may provide a reference for the occurrence and development mechanism of HCM. In addition, mutations in PRMT5 may be a useful therapeutic and diagnostic target for HCM. Our results also provide an independent quantitative assessment of functional limitations in patients with unknown history.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Cardiomyopathy I: Introduction and Classification
Pathophysiology of Heart Failure
Cardiomyopathy II: Dilated Cardiomyopathy
Myocarditis I: Introduction

